Cytochrome C suppresses renal accumulation and nephrotoxicity of polymyxin B

Z-D Li1,2, J Luo2, L-H Jia1

  • 11 Department of Pharmacy, Electric Power Teaching Hospital, Capital Medical University, Beijing, China.

Insights

Cytochrome c administration reduced kidney accumulation and toxicity of polymyxin B in rats. This suggests cytochrome c may protect against polymyxin B-induced kidney damage by interacting with the megalin receptor.

Area of Science:

  • Nephrology
  • Pharmacology
  • Cell Biology

Background:

  • The receptor megalin is implicated in the renal accumulation of polymyxin B (PMB) in vitro.
  • Understanding PMB's in vivo renal handling and toxicity is crucial for its clinical application.

Purpose of the Study:

  • To investigate the effect of cytochrome c (cyto c), a known megalin ligand, on the renal accumulation and nephrotoxicity of PMB in a rat model.
  • To further elucidate the role of megalin in PMB renal uptake.

Main Methods:

  • Thirty Sprague-Dawley rats were administered PMB intravenously, with or without varying doses of cyto c.
  • Renal PMB concentration, N-acetyl-β-D-glucosaminidase excretion, and kidney pathology were assessed.
  • Serum creatinine, blood urea nitrogen, and blood β2-microglobulin levels were measured.

Main Results:

  • Cyto c significantly decreased PMB accumulation in the kidneys in a dose-dependent manner (up to 39.1%).
  • Cyto c administration reduced N-acetyl-β-D-glucosaminidase excretion and ameliorated kidney pathological damage induced by PMB.
  • No significant changes were observed in serum creatinine, BUN, or blood β2-microglobulin levels.

Conclusions:

  • Cytochrome c demonstrates potential in inhibiting renal accumulation and nephrotoxicity of PMB in vivo.
  • These findings support the role of the megalin receptor in mediating PMB renal uptake and toxicity.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
480
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
7.5K
Renal Clearance01:23

Renal Clearance

The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
2.7K
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
620
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
289
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
266